1.Osborn AG,Hedlund GL,Salzman KL. Toxic, metabolic, degenerative and CSF disorders. In: Osborn’s Brain. 2nd ed. Philadelphia, Pa: Elsevier, 2017;905–1155.
2.De Oliveira AM,Paulino MV,Vieira APF,McKinney AM,da Rocha AJ,Dos Santos GT,Leite CDC,Godoy LFS,Lucato LT. Imaging Patterns of Toxic and Metabolic Brain Disorders. RadioGraphics 2019 39:6,1672-1695.
3.Wu Z,Mittal S,Kish K,Yu Y,Hu J,Haacke EM. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging. 2009;29(1):177–182.
4.Kruer MC,Boddaert N,Schneider SA, Houlden H, Bhatia KP, Gregory A, Anderson JC, Rooney WD, Hogarth P, Hayflick SJ. Neuroimaging Features of Neurodegeneration with Brain Iron Accumulation. AJNR 2012;33(3):407-414.
5.Yang J,Li X,Yang R et al. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients. PLoS One.2015;10(4):e0125100.
6.Grasso D,Borreggine C,Perfetto F et al. Lentiform fork sign: a magnetic resonance finding in a case of acute metabolic acidosis. Neuroradiol J. 2014;27(3):288–292.
7.Kumar G,Goyal MK. Lentiform fork sign: a unique MRI picture. Is metabolic acidosis responsible? Clin Neurol Neurosurg. 2010;112(9):805–812.
8.Kim TJ,Kim IO,Kim WS,Cheon JE,Moon SG,Kwon JW,Seo JK,Yeon KM. MR Imaging of the Brain in Wilson Disease of Childhood: Findings Before and After Treatment with Clinical Correlation. AJNR 2006;27(6):1373-1378.
9.Starkey J,Kobayashi N,Numaguchi Y,Moritani T. Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations. Radiographics. 2017 Mar-Apr;37(2):562-576.
10.Bartynski WS. Posterior reversible encephalopathy syndrome, part 1 and part 2: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036-49.
11.McKinney AM,Short J,Truwit CL,McKinney ZJ,Kozak OS,SantaCruz KS,Teksam M. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. (2007) AJR. American journal of roentgenology. 189(4):904-12.
12.Lamy C,Oppenheim C,Mas JL. Posterior reversible encephalopathy syndrome. Handb Clin Neurol. 2014;121:1687-701.
13.Miller TR,Shivashankar R,Mossa-Basha M,Gandhi D. Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course. AJNR Am J Neuroradiol. 2015;36 (8):1392.
14.Ducros A. Reversible cerebral vasoconstriction syndrome. (2012) The Lancet. Neurology. 11(10):906-17.
15.Katyal N,Narula N,George P,Nattanamai P,Newey CR,Beary JM. Delayed Post-hypoxic Leukoencephalopathy: A Case Series and Review of the Literature. Cureus.2018;10(4):e2481.
16.Jin Woo Choi,Won-Jin Moon. Gadolinium Deposition in the Brain: Current Updates. Korean J Radiol.2019 Jan;20(1):134–147.